Will biomarkers help? 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Ca https://t.co/AFfCftS3QJ
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
#ETUDESANTEDUSOIR Traité ou non, 1 cancer localisé de la prostate est rarement fatal ds les 10 ans qui suivent https://t.co/EXla8L7UpZ @NEJM
Beware of prostate cancer screening. Interesting info from @NEJM here: https://t.co/sdlKu1EIry #prostatecancer #primarycare #TheMoreYouKnow
Resultados a 10 años del cáncer de próstata localizado mediante supervisión activa, cirugía o radioterapia. https://t.co/kIvQjukIC2
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @CSR_Bris: The RCT they said could never be done: ProtecT published in NEJM.https://t.co/6rLH9ognpB https://t.co/NRiBZHUcy9
RT @Charlotte_Huff: More data @NEJM re: watchful waiting option for prostate cancer: https://t.co/fYB8TwbAM5, but is there any angst? https…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @RaulCalvoRico: 1,5/1000 fallecidos año x Ca d próstata si sólo se monitoriza. 0,9 si prostatectomia radical, 0,7 si radioterapia. http…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/Z0NHSJaExB
must read #erus2016: https://t.co/c0PgNfMdiP
protect must read: https://t.co/c0PgNfMdiP
RT @pbagnall60: And finally we have the results of the ProtecT study @BAUNnurses https://t.co/nCtx7Y2Dls
RT @hseino1: 原著論文はこちらhttps://t.co/8sKYpatfO5。一般的ながん検診の有効の議論はこちら「がん検診についてhttps://t.co/xDh1PGIGhq」/初期の前立腺がん 治療の有無で生存率にほぼ差なしhttps://t.co/7ktUK…
RT @zoeharcombe: Prostate cancer (NB men tend to die with, not from) - monitoring not sig diff to surgery/radiotherapy & no SAEs https://t…
RT @CSR_Bris: The RCT they said could never be done: ProtecT published in NEJM.https://t.co/6rLH9ognpB https://t.co/NRiBZHUcy9
El enlace-link creo que es: https://t.co/scN4BEqWOl https://t.co/C6vBAKIUZR
@caseofdees @trouw Hier. Dacht dat het het NYT stuk dat ik een dag of zo geleden las https://t.co/nDhoJYLnAW Hier
10Y Outcomes after AS, Surgery, or RTH for Localized PCa: No difference for OS but more PFS in the Monitoring group https://t.co/zZuG5xU4QO
The RCT they said could never be done: ProtecT published in NEJM.https://t.co/6rLH9ognpB https://t.co/NRiBZHUcy9
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
RT @Vilavaite: #ProtecT trial ⬇#prostatecancer mortality irrespective of treatment #activemonitoring @NEJM https://t.co/dVV0kUdxNT https:/…
#ProtecT trial ⬇#prostatecancer mortality irrespective of treatment #activemonitoring @NEJM https://t.co/dVV0kUdxNT https://t.co/K606ivqS80
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @FarmaOnco: "10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer" https://t.co/2NiNP52SXl
"10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer" https://t.co/2NiNP52SXl
Prostate #cancer as a chronic disease. #GeriOnc https://t.co/yGutb2JLz3
La efectividad comparativa de los tratamientos del cáncer próstata detectado por PSA es incierto #SegPac #Ptsafety https://t.co/aLM8iu78kr
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
[MEDICINE] 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer #MedEd #Scien… https://t.co/lydgkikyvw
RT @CIgenomics: ProtecT prostate cancer trial results in @NEJM https://t.co/0fypD727Ik Maybe PSA is not so bad after all?
RT @_JosephLi: Surgery, radiation & active monitoring all assoc w low mortality in localized prostate CA: a 10 yr study https://t.co/BXzBRI…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. https://t.co/gOBkXb8hJL
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @JuanGrvas: Localized prostate cancer Monitoring, surgery or radiotherapy Equal mortality. Different course, and adverse effects https:/…
how discussions of prostate cancer and its treatment is experienced https://t.co/ZAUYDGGZNf and debates go on: https://t.co/lyF6IMEW6f
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer https://t.co/ODODW05LNg @NEJM
Fantastic article in #NEJM today on #PancreaticCancer survival - no difference between treatments if caught early...https://t.co/J9aYANbbyA
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
RT @KirkChris: As a patient, I was part of this clinical trial. Participation important even when conclusions complex! #ProtecT https://t.…
1,5/1000 fallecidos año x Ca d próstata si sólo se monitoriza. 0,9 si prostatectomia radical, 0,7 si radioterapia. https://t.co/sIq8vrZNXI
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
Important study on prostate cancer outcomes. @NEJM https://t.co/iNG7kznG7F
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
Men with early prostate cancer can safely opt out of treatment, finds landmark study https://t.co/9BBBCTosMI
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
RT @JuanGrvas: Cáncer próstata localizado Igual mortalidad vigilancia, cirugía o radioterapia Diferente evolución/ efectos adversos https:/…
@arropT @NYTHealth Aqui tienes el editorial del NEJM https://t.co/qFBP8meyYH y el articulo https://t.co/MLc9VFzEDt
Important #ProtecT study published in @NEJM this week. Monitoring vs Radiotherapy vs Surgery for #prostatecancer https://t.co/TAngn552z0
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
早期前立腺癌への手術・RT・ASのPC因10年死亡率同等性を確認:ProtecT Study Group。 https://t.co/lV9p4Fk8jW
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @sabinbmotwanimd: Long awaited results of the ProtecT study in @NEJM published today https://t.co/2rstXGHllD. #radonc #pcsm
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @petergorayski: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/8OBb4nMPhX
RT @JackOSullivan3: No mortality difference between monitoring, surgery or radiotherapy 10 years after #prostate cancer diagnosis @NEJM htt…
RT @sandraturner49: Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin ht…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/ENv5fCl0PL
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/LTnfXzpVMq
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/Zczb3vzqYu
RT @MRCRWG: Pioneering methodological work enabled successful recruitment to the ProtecT trial https://t.co/QKtsPDzIHP
Few deaths & no diff amongst treatment modalities @picardonhealth10-Yr f/u for Localized #ProstateCancer — NEJM https://t.co/UhC27ndXyt
RT @MRCRWG: Pioneering methodological work enabled successful recruitment to the ProtecT trial https://t.co/QKtsPDzIHP
RT @Charlotte_Huff: More data @NEJM re: watchful waiting option for prostate cancer: https://t.co/fYB8TwbAM5, but is there any angst? https…
RT @JuanGrvas: Cáncer próstata localizado Igual mortalidad vigilancia, cirugía o radioterapia Diferente evolución/ efectos adversos https:/…
Landmark study on prostate cancer in this week's journal https://t.co/SfMhbThs7o
RT @sandraturner49: Radiation therapy as good as surgery for prostate cancer. @JillMargo1 @TargetingCancer @cancerNSW @DrTPShakespeare http…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/nYpRsommnp
RT @prokarurol: As I read the notification from the @nytimes I wondered about "mixed messages" - a negative, positive trial? https://t.co/B…
RT @sandraturner49: Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin ht…
RT @LeilaRooshenas: Fresh evidence on treatment outcomes for early stage prostate cancer - ProtecT findings: https://t.co/Ho0h8vbzDi https:…
RT @CMichaelGibson: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/YvqGjEthWT
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @sandraturner49: Great news for men w prostate ca. Effective choices- talk to a radiation oncologist @TargetingCancer @JulieMcCrossin ht…
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — @NEJM https://t.co/2pfwvOpMwE @NEJM
RT @MaryDixonWoods: Huge, lengthy trial of interventions for clinically localized prostate cancer reports. https://t.co/mFVbzuPjjA
RT @CMichaelGibson: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/YvqGjEthWT
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/HE12pqjRzY
RT @LoebStacy: Hot off the press: ProtecT randomized trial surgery vs radiation vs active monitoring for #prostatecancer in @NEJM https://…
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/LXAPFJUPo5
More data @NEJM re: watchful waiting option for prostate cancer: https://t.co/fYB8TwbAM5, but is there any angst? https://t.co/CghrDYjej8
Surgery, radiation & active monitoring all assoc w low mortality in localized prostate CA: a 10 yr study https://t.co/BXzBRIPybC
RT @NEJM: Original Article: Mortality and Clinical Outcomes in the ProtecT Trial https://t.co/nlI4wTKhlu #prostatecancer https://t.co/NH2nC…
RT @MaryDixonWoods: Huge, lengthy trial of interventions for clinically localized prostate cancer reports. https://t.co/mFVbzuPjjA
RT @zoeharcombe: Prostate cancer (NB men tend to die with, not from) - monitoring not sig diff to surgery/radiotherapy & no SAEs https://t…
RT @CMichaelGibson: 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer — NEJM https://t.co/YvqGjEthWT
RT @LeilaRooshenas: Fresh evidence on treatment outcomes for early stage prostate cancer - ProtecT findings: https://t.co/Ho0h8vbzDi https:…
Fresh evidence on treatment outcomes for early stage prostate cancer - ProtecT findings: https://t.co/Ho0h8vbzDi https://t.co/8e5mYrBS2g